Literature DB >> 33617510

Thoracic Surgeon Impressions of the Impact of the COVID-19 Pandemic on Lung Cancer Care-Lessons from the First Wave in Canada.

Roy A Hilzenrat1, Shaun A Deen2,3, John Yee2,4,5, Kyle A Grant2,4, Ahmad S Ashrafi2,6, Shaun Coughlin2,7, Anna L McGuire2,4,5.   

Abstract

BACKGROUND: COVID-19 has invariably changed the way lung cancer surgical care is provided in Canada. Despite relevant management guidelines, the way in which cancer care has been affected has yet to be described for thoracic surgical populations. Routine lung cancer physiologic and staging assessments are unique in that they are droplet producing and aerosolizing procedures. Our objective was to quantify the effect of the COVID-19 pandemic on surgical lung cancer care as perceived by practicing thoracic surgeons during the first wave of the pandemic in Canada.
METHODS: An electronic survey was distributed to members of the Canadian Association of Thoracic Surgeons. The survey was designed to determine surgeon perception of lung cancer preoperative care during the Canadian pandemic-instilled period of resource reallocation compared to standard care. Planned analyses were exploratory in nature; with count and frequency distributions of responses quantified.
RESULTS: Fifty-three thoracic surgeons completed the survey. Responses were collected from all Canadian provinces. Little change in access to preoperative imaging was noted. However, a significant decrease in access to lung function and bronchoscopy testing occurred. Pulmonary surgery was perceived to be lengthier with reduced operating theater availability. Despite decreased OR access, only 40% of surgeons were aware of respective institutional mitigation strategies.
SUMMARY: The COVID-19 pandemic has had an impact on standard lung cancer care preoperative workup. Further inquiry using institutional data is warranted to quantify its impact on cancer patient outcomes. Assessing the extent and effects of newly present barriers to standard lung cancer care is essential in forming appropriate mitigation strategies and planning for future pandemic waves.

Entities:  

Keywords:  COVID-19; Canada; cancer care; lung cancer; survey; thoracic malignancy

Mesh:

Year:  2021        PMID: 33617510      PMCID: PMC7985774          DOI: 10.3390/curroncol28010092

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  18 in total

1.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

2.  Performance at symptom-limited stair-climbing test is associated with increased cardiopulmonary complications, mortality, and costs after major lung resection.

Authors:  Alessandro Brunelli; Majed Refai; Francesco Xiumé; Michele Salati; Valeria Sciarra; Laura Socci; Armando Sabbatini
Journal:  Ann Thorac Surg       Date:  2008-07       Impact factor: 4.330

3.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

Authors:  Peter Goldstraw; Kari Chansky; John Crowley; Ramon Rami-Porta; Hisao Asamura; Wilfried E E Eberhardt; Andrew G Nicholson; Patti Groome; Alan Mitchell; Vanessa Bolejack
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

4.  Value of preoperative 6-minute walk test for predicting postoperative pulmonary complications.

Authors:  Warangkana Keeratichananont; Chokchai Thanadetsuntorn; Suriya Keeratichananont
Journal:  Ther Adv Respir Dis       Date:  2015-11-06       Impact factor: 4.031

5.  Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Alessandro Brunelli; Anthony W Kim; Kenneth I Berger; Doreen J Addrizzo-Harris
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

6.  Covid-19 and lung cancer: A greater fatality rate?

Authors:  Jacobo Rogado; Cristina Pangua; Gloria Serrano-Montero; Berta Obispo; Almudena Martín Marino; Mar Pérez-Pérez; Ana López-Alfonso; Pedro Gullón; Miguel Ángel Lara
Journal:  Lung Cancer       Date:  2020-05-30       Impact factor: 5.705

7.  Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group.

Authors:  Clarissa Baldotto; Ana Gelatti; Arthur Accioly; Clarissa Mathias; Eldsamira Mascarenhas; Heloisa Carvalho; Lilian Faroni; Luiz Henrique Araújo; Mauro Zukin; Rafael Gadia; Ricardo Mingarini Terra; Rui Haddad; Vladmir Cordeiro de Lima; Gilberto de Castro-Júnior
Journal:  Clinics (Sao Paulo)       Date:  2020-06-22       Impact factor: 2.365

8.  COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network.

Authors:  Mara Antonoff; Leah Backhus; Daniel J Boffa; Stephen R Broderick; Lisa M Brown; Phillip Carrott; James M Clark; David Cooke; Elizabeth David; Matt Facktor; Farhood Farjah; Eric Grogan; James Isbell; David R Jones; Biniam Kidane; Anthony W Kim; Shaf Keshavjee; Seth Krantz; Natalie Lui; Linda Martin; Robert A Meguid; Shari L Meyerson; Tim Mullett; Heidi Nelson; David D Odell; Joseph D Phillips; Varun Puri; Valerie Rusch; Lawrence Shulman; Thomas K Varghese; Elliot Wakeam; Douglas E Wood
Journal:  J Thorac Cardiovasc Surg       Date:  2020-04-09       Impact factor: 5.209

9.  Time-to-Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute.

Authors:  Ping Yuan; Jin Lin Cao; Azmat Rustam; Chong Zhang; Xiao Shuai Yuan; Fei Chao Bao; Wang Lv; Jian Hu
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

10.  Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.

Authors:  L Zhang; F Zhu; L Xie; C Wang; J Wang; R Chen; P Jia; H Q Guan; L Peng; Y Chen; P Peng; P Zhang; Q Chu; Q Shen; Y Wang; S Y Xu; J P Zhao; M Zhou
Journal:  Ann Oncol       Date:  2020-03-26       Impact factor: 32.976

View more
  1 in total

1.  The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review.

Authors:  Goulnar Kasymjanova; Aksa Anwar; Victor Cohen; Khalil Sultanem; Carmela Pepe; Lama Sakr; Jennifer Friedmann; Jason S Agulnik
Journal:  Curr Oncol       Date:  2021-10-20       Impact factor: 3.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.